Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
PTC Therapeutics, Inc. (PTCT)  
$48.82 0.12 (0.25%) as of 4:30 Fri 8/15


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 90,552,000
Market Cap: 4.42(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $31.42 - $57.17
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  557
Guru Rank Value     : 3.3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   PTC Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of clinically-differentiated medicines that provide benefits to patients with rare disorders. Co. has the following products, Translarna™ (ataluren) and Emflaza® (deflazacort), for the treatment of Duchenne muscular dystrophy, a rare, life threatening disorder. Co.'s gene therapy product candidates for rare monogenic diseases that affect the central nervous system (CNS) include PTC- Aromatic L-Amino Acid Decarboxylase (AADC) for the treatment of AADC deficiency, a rare CNS disorder arising from reductions in the enzyme AADC that results from mutations in the dopa decarboxylase gene.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 7,700
Total Buy Value $0 $0 $0 $198,736
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 13,255 135,117 372,474 458,756
Total Sell Value $680,077 $7,081,777 $19,250,065 $22,010,282
Total People Sold 2 9 10 12
Total Sell Transactions 2 28 49 79
End Date 2025-05-18 2025-02-14 2024-08-16 2023-08-17

   
Records found: 523
  Page 1 of 21  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Klein Matthew B. CHIEF EXECUTIVE OFFICER   •       •      –    2025-08-05 4 S $51.74 $555,636 D/D (10,739) 337,767 5%     
   Klein Matthew B. CHIEF EXECUTIVE OFFICER   •       •      –    2025-08-01 4 A $0.00 $0 D/D 75,000 348,506     -
   Gravier Pierre CHIEF FINANCIAL OFFICER   •       –      –    2025-07-15 4 S $49.46 $124,441 D/D (2,516) 71,920 -2%     
   Boulding Mark Elliott EXEC. VP AND CLO   •       –      –    2025-05-16 4 AS $46.02 $40,636 D/D (883) 103,901 -1%     
   Boulding Mark Elliott EXEC. VP AND CLO   •       –      –    2025-05-16 4 OE $25.69 $22,684 D/D 883 104,784     -
   Boulding Mark Elliott EXEC. VP AND CLO   •       –      –    2025-05-15 4 AS $46.18 $89,081 D/D (1,929) 103,901 0%     
   Boulding Mark Elliott EXEC. VP AND CLO   •       –      –    2025-05-15 4 OE $25.69 $49,556 D/D 1,929 105,830     -
   Klein Matthew B. CHIEF EXECUTIVE OFFICER   •       •      –    2025-04-22 4 S $48.74 $136,656 D/D (2,804) 273,234 -1%     
   Golden Lee Scott EVP & CHIEF MEDICAL OFFICER   •       –      –    2025-04-02 4 S $46.95 $42,114 D/D (897) 75,997 6%     
   Pauwels Eric CHIEF BUSINESS OFFICER   •       –      –    2025-03-17 4 AS $55.24 $384,067 D/D (6,762) 72,640 -22%     
   Pauwels Eric CHIEF BUSINESS OFFICER   •       –      –    2025-03-14 4 AS $55.19 $246,037 D/D (4,458) 79,402 -15%     
   Okey Stephanie   –       •      –    2025-03-13 4 S $54.00 $270,000 D/D (5,000) 8,867 11%     
   Boulding Mark Elliott EXEC. VP AND CLO   •       –      –    2025-03-11 4 AS $53.01 $391,323 D/D (7,381) 103,901 -9%     
   Boulding Mark Elliott EXEC. VP AND CLO   •       –      –    2025-03-11 4 OE $33.02 $243,721 D/D 7,381 105,620     -
   Boulding Mark Elliott EXEC. VP AND CLO   •       –      –    2025-03-10 4 AS $52.24 $3,611,982 D/D (68,039) 103,901 -9%     
   Boulding Mark Elliott EXEC. VP AND CLO   •       –      –    2025-03-10 4 OE $25.69 $2,164,193 D/D 68,039 115,150     -
   Jacobson Allan Steven   –       •      –    2025-03-04 4 S $51.52 $63,370 D/D (1,230) 19,118 5%     
   Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER   •       –      –    2025-02-20 4 S $50.12 $1,704 I/I (34) 5,907 4%     
   Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER   •       –      –    2025-02-20 4 S $50.12 $79,096 D/D (1,578) 100,353 4%     
   Gravier Pierre CHIEF FINANCIAL OFFICER   •       –      –    2025-02-20 4 S $50.12 $58,495 D/D (1,167) 74,436 4%     
   Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER   •       –      –    2025-02-20 4 S $50.12 $44,009 D/D (878) 62,564 4%     
   Boulding Mark Elliott EXEC. VP AND CLO   •       –      –    2025-02-20 4 S $50.12 $80,900 D/D (1,614) 103,901 4%     
   Pauwels Eric CHIEF EXECUTIVE OFFICER   •       –      –    2025-02-20 4 S $50.12 $78,544 D/D (1,567) 83,860 4%     
   Klein Matthew B. CHIEF EXECUTIVE OFFICER   •       •      –    2025-02-20 4 S $50.12 $195,233 D/D (3,895) 276,038 4%     
   Golden Lee Scott EVP & CHIEF MEDICAL OFFICER   •       –      –    2025-02-20 4 S $50.12 $48,219 D/D (962) 76,894 4%     
  523 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 21
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us